| Message : | I'm sorry, I'm not interested http://www.muffandteacake.co.uk/tecnopharmanet-2986.pdf#tower bestrxmeds.com The company, which develops therapies based onplacenta-derived stem cells, said it received a U.S. patent forits methods in the treatment of peripheral artery disease - acondition in which blood vessels narrow, blocking the supply ofblood to arms and legs.
***---REPLIED TO MESSAGE BELOW---***
I'm sorry, I'm not interested http://www.muffandteacake.co.uk/tecnopharmanet-2986.pdf#tower bestrxmeds.com The company, which develops therapies based onplacenta-derived stem cells, said it received a U.S. patent forits methods in the treatment of peripheral artery disease - acondition in which blood vessels narrow, blocking the supply ofblood to arms and legs.
|